FGK Clinical Research GmbH

FGK Clinical Research is a Europe-based CRO of an ideal size for cooperation with smaller and middle-size biotech, pharmaceutical or medical device companies. We currently have 140 employees in-house at our offices – all very experienced in their own fields and trained according to the latest standards in clinical research.

The size of FGK allows us to provide you with the complete range of clinical development services yet remain flexible enough to tailor our services specifically to your exact needs and respond quickly to your demands. In addition to extensive experience in the pharmaceutical industry, we perfectly understand the culture and environment of small and emerging companies.

FGK opened a branch office in Berlin in March 2020. The Berlin office will support the operative units at the German headquarters in Munich.

FGK is a member of “Bundesverband Medizinischer Auftragsinstitute” (BVMA) since 2007.The BVMA was founded in July 1991 in order to represent CROs (Contract Research Organisations) which are based in Germany or German speaking countries. The BVMA is based in Munich. At present 40 companies, operating in the field of clinical research at a national as well as international level, are members of the Association (status: April 2017). In order to make sure that each member satisfies the high quality demands, all members undergo re-auditing every three years. In November 2017, FGK’s Managing Director Martin Krauss has been elected as new President of the BVMA. He has been an Executive Board member of the BVMA before and now succeeds Dr. Dagmar Chase who has previously led the association for 16 years.